Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Genome-wide Association Studies-GWAS
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Random Error
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 25, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Yunda Zhang1, Haiqun Xia2, Shengfei Yang3
1Department of General Surgery, Dongguan Songshan Lake Tungwah Hospital, Dongguan, China.
Thyroid diseases like hypothyroidism and Hashimoto thyroiditis increase autoimmune hepatitis risk. Autoimmune hepatitis does not appear to cause thyroid disease, according to this Mendelian randomization study.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: